This intricate network of communication between BMI1, BORIS/CTCFL and Wnt signaling plays a crucial role that confers therapeutic resistance and malignancy in the aggressive MYCN-amplified NB cell line. This evidence concerns the gene CTCFL and neuroblastoma.